In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1890 News Items found
Pictured: Joan Massagué
Announcement
Cancer Biologist Joan Massagué Named Director of the Sloan Kettering Institute

Internationally recognized cancer biologist Joan Massagué has been named Director of the Sloan Kettering Institute. He was previously Chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering.
The 1986 explosion at the Chernobyl nuclear power plant released radioactive particles in every direction.
In the Lab
Study Reveals Genetic Causes for Thyroid Cancer Increase after Chernobyl

The study of some victims exposed to ionizing radiation from the 1986 Chernobyl nuclear power plant accident is yielding new information about how radiation-induced thyroid cancer develops.
Pictured: Stephen Long & Alexandria Miller
Profile
At Work: Structural Biologist Stephen Long

Stephen Long works to understand how proteins work by determining what they look like in three dimensions.
Pictured: Craig Thompson
Event
Watch Webcast of “Major Trends” Seminar — Annual Event for High School Students

Memorial Sloan Kettering’s annual seminar exposes high school students and their teachers to cutting-edge scientific research.
Pictured: Laurie Glimcher, Craig Thompson, Marc Tessier-Lavigne & Tadataka Yamada
Announcement
Innovative Partnership Will Speed Drug Discovery and Development

Memorial Sloan Kettering is joining with two other academic institutions in a pioneering collaboration to speed early-stage drug discoveries into therapies for patients.
Pictured: Emily Foley
Profile
At Work: Cell Biologist Emily Foley

Memorial Sloan Kettering cell biologist Emily Foley discusses her research, which is focused on improving the understanding of cell division.
Mouse glioblastoma tumor with phagocytic macrophages
In the Lab
Immune Cells in the Brain Could be Enlisted to Fight Glioblastoma

Memorial Sloan Kettering researchers say a drug that acts on noncancerous, tumor-infiltrating cells might provide a new treatment option for the most common and aggressive type of brain cancer.
Pictured: James E. Rothman, Thomas C. Südhof & Randy W. Schekman
Honors
Former Memorial Sloan Kettering Researcher James Rothman Among Nobel Prize Winners

James Rothman, who receives this year’s Nobel Prize in Physiology or Medicine together with Randy Schekman and Thomas Südhof, conducted more than a decade of his seminal research at Memorial Sloan Kettering.
Breast cancer mosaic
Snapshot
New Technology Could Enable Immediate Detection of Tumor Borders during Surgery

Memorial Sloan Kettering scientists are developing new imaging instrumentation that could enable pathologist and surgeons to collaborate more seamlessly and reduce the need for repeat surgeries.
Pictured: Pseudomonas aeruginosa
Snapshot
The Social Behavior of Bacteria Offers New Ideas for Antimicrobial Drug Design

Memorial Sloan Kettering researchers have discovered how a common bacterium can evolve to become more mobile and easier to get rid of.